Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Triple Negative Breast Cancer
Interventions: DRUG: Adebrelimab|DRUG: Vinorelbine|DRUG: Cyclophosphamide (tablet)|DRUG: Capecitabine
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences